Gyn Onc Prehab Study

Sponsor
St. Louis University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04298827
Collaborator
(none)
164
1
2
43.3
3.8

Study Details

Study Description

Brief Summary

Patients will be randomized to a unimodal or trimodal prehabilitation program prior to surgery for known or suspected gynecologic cancer.

Condition or Disease Intervention/Treatment Phase
  • Other: Unimodal
  • Other: Trimodal
N/A

Detailed Description

Prehabilitation generally refers to the act of an intervention prior to a known potentially debilitating event. Usually taking the form of physical therapy prior to surgery, prehabilitation programs have demonstrated success in colorectal, urological, and surgical oncology cases. Patients with a gynecologic oncology diagnosis face an arduous course. Their treatment generally involves a major surgery and is often followed by chemotherapy, radiation, or both.The patient population is generally older in life as the average age for an endometrial or ovarian cancer diagnosis is 63. These patients may already have a lower performance status at baseline deeming their treatment course exponentially more difficult to endure. Women with gynecologic cancer suffer significant mental duress often living in fear of the high rates of recurrence from some of these malignancies suggesting they may benefit from psychologic support and counseling through their treatment.

Given the proven success in other surgical disciplines, we believe that instituting prehabilitation programs should be standard of care. Patients will be randomized to a trimodal approach (physical therapy, nutritional counseling, cognitive behavioral therapy) versus a unimodal intervention (physical therapy) for a formal prehabilitation program. Our primary outcome will be functional return to baseline following surgery with secondary outcomes including items such as quality of life assessments, patient satisfaction, and compliance.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
164 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Optimizing Prehabilitation in Gynecologic Oncology
Actual Study Start Date :
Jul 21, 2020
Anticipated Primary Completion Date :
Mar 1, 2024
Anticipated Study Completion Date :
Mar 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Unimodal

Patients will be randomized at their pre-surgical consultation. Patients will undergo a physical therapy evaluation prior to surgery and at 4 and 8 weeks post-op. Their preoperative visits will be as close to 4 weeks before surgery as possible but given the urgency of some of these surgeries and diagnoses, treatment will not be delayed to complete the components of this study. The patient will also be asked to complete a quality of life assessment at the beginning and end of the study as well as an anonymous survey at the conclusion of the study evaluating her satisfaction with the experiment.

Other: Unimodal
Patients will receive physical therapy alone.

Active Comparator: Trimodal

Patients will be randomized at their pre-surgical consultation. Patients will undergo a physical therapy evaluation, nutritional counseling and group therapy, prior to surgery and at 4 and 8 weeks post-op. Their preoperative visits will be as close to 4 weeks before surgery as possible but given the urgency of some of these surgeries and diagnoses, treatment will not be delayed to complete the components of this study. The patient will also be asked to complete a quality of life assessment at the beginning and end of the study as well as an anonymous survey at the conclusion of the study evaluating her satisfaction with the experiment. Patient nutritional assessments will be obtained with Patient Generated Subjective Global Assessment questionnaires as well as targeted questioning by the dietician.

Other: Trimodal
Patients will receive physical therapy, nutrition counseling, and cognitive behavioral therapy in the form of group counseling.

Outcome Measures

Primary Outcome Measures

  1. Timed Up and Go [During the approximate 12 week study period]

    Patients will have a preoperative physical therapy assessment incorporating standard evaluations of a 6 minute walk test, grip strength, and timed up and go. These will serve as the individual patient's baseline for subsequent comparison after surgery.

  2. Six Minute Walk Test [During the approximate 12 week study period]

    Patients will have a preoperative physical therapy assessment incorporating standard evaluations of a 6 minute walk test, grip strength, and timed up and go. These will serve as the individual patient's baseline for subsequent comparison after surgery.

  3. Grip Strength [During the approximate 12 week study period]

    Patients will have a preoperative physical therapy assessment incorporating standard evaluations of a 6 minute walk test, grip strength, and timed up and go. These will serve as the individual patient's baseline for subsequent comparison after surgery.

Secondary Outcome Measures

  1. Readmission Rates [During the 8 weeks after surgery (12 week approximate total study period)]

    Need for postoperative readmission with be monitored in each group.

  2. Complication Rates [During the 12 week approximate total study period]

    Surgical or treatment complications with be monitored in each group.

  3. Patient Satisfaction [At the conclusion of the approximate 12 week study period]

    Patients from each group will be asked to complete an anonymous survey evaluating their satisfaction with the program.

  4. Quality of Life FACT-G Assessment [During the 12 week approximate total study period]

    Patients will complete baseline and follow up quality of life assessments using the FACT-G (Functional Assessment of Cancer Therapy-General). This is a 28 question quality of life assessment with scores ranging from 0 to 112 (higher scores correlate with a higher quality of life).

  5. Treatment Completion [At the conclusion of the 12 week approximate total study period]

    Rate of program completion will be assessed for each group.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patient who will be undergoing a planned surgery for known or presumed gynecologic cancer diagnosis.
Exclusion Criteria:
  • Non-English speaking patients

  • Surgeries done for palliative intent

  • Poor performance status or other inability to participate in physical therapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Saint Louis University Saint Louis Missouri United States 63104

Sponsors and Collaborators

  • St. Louis University

Investigators

  • Principal Investigator: Shannon Grabosch, MD, St. Louis University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Shannon Grabosch, MD, Assistant Professor of Gynecologic Oncology, St. Louis University
ClinicalTrials.gov Identifier:
NCT04298827
Other Study ID Numbers:
  • 30334
First Posted:
Mar 6, 2020
Last Update Posted:
Apr 15, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 15, 2022